Author:
Wu Ping,Xu Baoping,Shen Adong,Zeng Huasong,Shen Kunling
Abstract
Abstract
Objective
To analyze the asthma medication use in Chinese children of different age groups, regions, and levels of cities in China, based on the 2015 Healthcare Insurance Data in China.
Methods
The China Healthcare Insurance Research Association (CHIRA) database was searched for children from 0 to 14 years old diagnosed as asthma based on the “J45” and “J46” coded in ICD-10. A cross-sectional study design was employed.
Results
A total of 308,550 children were identified, all of whom were treated under the coverage of healthcare insurance. Among them, 2,468 children were eligible for inclusion in the present study. Compared with the current status of asthma care in European and American countries, under the guidelines for the diagnosis and treatment of asthma in China, the use percentages of ICS and short-acting β2 receptor agonist in children with asthma in China were lower, but the use percentages of oral corticosteroids, long-acting β2 receptor agonist, and theophylline (especially intravenous theophylline) were higher, especially in the Central and West China.
Conclusion
The asthma medication use was attributed to many factors, thus efforts are still needed to further popularize the GINA programs and China's guidelines for asthma diagnosis and treatment, especially in the Central and West China.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference34 articles.
1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. EurRespir J. 2008;31(1):143–78.
2. Chen Z, Wang P, Shen H. Asthma research in China: A five-year review. Respirology. 2013;18(S3):10–9.
3. National Cooperative Group on Childhood Asthma, Institute of Environmental Health and Related Product Safety, Chinese Center for Disease Control and Prevention. [Third nationwide survey of childhood asthma in urban areas of China]. Zhonghua Er Ke Za Zhi. 2013;51(10):729–735. (In Chinese)
4. Su N, Lin J, Liu G, Chen P, Zhou X, Wan H, et al. An epidemiological survey of current asthma control status in China. Zhonghua Nei Ke Za Zhi. 2014;53(8):601–6 ((In Chinese)).
5. Chen Z. Guidelines for the diagnosis and prevention of bronchial asthma in children (2016 edition). Chinese J Pediatr. 2016;54(3):167–81.